Connect your AI

Innoviva, Inc. INVA Earnings yield

Earnings yield at other companies

PfizerPFE

6.8%—

Merck & Co.MRK

3%-4.7pp

AbbVieABBV

0.9%-0.2pp

InsmedINSM

-3.4%-1.2pp

Ionis PharmaceuticalsIONS

-2.6%-1.1pp

ArriVent BioPharma, Inc.AVBP

-14.2%-3.3pp

Other financials

Income statement

Revenue$98.0M+10.6%

Gross profit$75.8M+3.4%

Operating income$38.2M-7.9%

Net income$186.6M+501%

EPS (diluted)$2.22+400%

Balance sheet

Cash & equivalents$603.1M+89.0%

Total debt$269.4M-40.3%

Total equity$1.3B—

Total assets$1.8B+46.4%

Cash flow

Operating cash flow$35.3M-27.4%

CapEx$492.0K—

Free cash flow$34.8M-28.4%

Valuation

Market cap$1.74B+51.8%

Profitability

Gross margin73.7%-9.9pp

Operating margin38.1%-11.2pp

Net margin119.9%+107pp

FCF margin54.1%+5.3pp

Returns & leverage

Return on equity29.1%—

Debt / equity0.2×—

Current ratio21.1×+18.7×

Where this comes from

Calculated from Innoviva, Inc.’s reported figures.

net income/market cap=29.2%

Based on trailing twelve months.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Innoviva, Inc.'s earnings yield?: Innoviva, Inc. (INVA) reported earnings yield of 29.2% in Q1 2026.
How has Innoviva, Inc.'s earnings yield changed year-over-year?: Innoviva, Inc.'s earnings yield increased by 656.1% year-over-year, from -5.3% to 29.2%.
What is the long-term trend for Innoviva, Inc.'s earnings yield?: Over 4 years (2020 to 2025), Innoviva, Inc.'s earnings yield has grown at a -14.6% compound annual growth rate (CAGR), from 34.1% to 18.1%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.